Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

Cesare Hassan, V Rinaldi, A Zullo, V De Francesco, S Winn, V Stoppino, D Faleo, Af Attili

Risultato della ricerca: Contributo in rivistaArticolo in rivista

72 Citazioni (Scopus)

Abstract

It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further treated with a quadruple therapy. Nevertheless, conflicting results have been reported using these treatment regimens in different countries.
Lingua originaleEnglish
pagine (da-a)163-168
Numero di pagine6
RivistaALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume13
Stato di pubblicazionePubblicato - 1999
Pubblicato esternamenteYes

Keywords

  • Adolescent
  • Adult
  • Aged
  • Bismuth
  • Drug Therapy, Combination
  • Female
  • Helicobacter Infections
  • Helicobacter pylori
  • Histamine H2 Antagonists
  • Humans
  • Male
  • Middle Aged
  • Proton Pumps
  • Ranitidine

Fingerprint Entra nei temi di ricerca di 'Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy'. Insieme formano una fingerprint unica.

Cita questo